Alnylam Pharmaceuticals, Inc. (ALNY)
232.68
+8.15
(+3.63%)
USD |
NASDAQ |
Oct 09, 16:00
233.00
+0.32
(+0.14%)
After-Hours: 20:00
Alnylam Pharmaceuticals Free Cash Flow (Quarterly) : 292.04M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 292.04M |
| March 31, 2026 | 48.67M |
| December 31, 2025 | 140.26M |
| September 30, 2025 | 312.97M |
| June 30, 2025 | 115.51M |
| March 31, 2025 | -129.28M |
| December 31, 2024 | -103.76M |
| September 30, 2024 | 39.52M |
| June 30, 2024 | 116.14M |
| March 31, 2024 | -94.49M |
| December 31, 2023 | -45.10M |
| September 30, 2023 | 342.32M |
| June 30, 2023 | -74.90M |
| March 31, 2023 | -180.37M |
| December 31, 2022 | -153.61M |
| September 30, 2022 | -131.79M |
| June 30, 2022 | -138.87M |
| March 31, 2022 | -189.05M |
| December 31, 2021 | -172.03M |
| September 30, 2021 | -160.10M |
| June 30, 2021 | -133.10M |
| March 31, 2021 | -252.84M |
| December 31, 2020 | -144.81M |
| September 30, 2020 | -122.74M |
| June 30, 2020 | -151.99M |
| Date | Value |
|---|---|
| March 31, 2020 | -265.78M |
| December 31, 2019 | -234.78M |
| September 30, 2019 | -218.69M |
| June 30, 2019 | 267.45M |
| March 31, 2019 | -232.56M |
| December 31, 2018 | -187.97M |
| September 30, 2018 | -199.22M |
| June 30, 2018 | -125.40M |
| March 31, 2018 | -176.92M |
| December 31, 2017 | -123.77M |
| September 30, 2017 | -124.04M |
| June 30, 2017 | -102.70M |
| March 31, 2017 | -136.48M |
| December 31, 2016 | -98.22M |
| September 30, 2016 | -95.83M |
| June 30, 2016 | -82.77M |
| March 31, 2016 | -95.44M |
| December 31, 2015 | -56.16M |
| September 30, 2015 | -60.84M |
| June 30, 2015 | -56.72M |
| March 31, 2015 | -28.36M |
| December 31, 2014 | -40.16M |
| September 30, 2014 | -43.90M |
| June 30, 2014 | -48.48M |
| March 31, 2014 | -42.06M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 547.30M |
| BridgeBio Pharma, Inc. | -71.54M |
| Regeneron Pharmaceuticals, Inc. | 521.80M |
| Vertex Pharmaceuticals, Inc. | 1.013B |
| Pfizer Inc. | 302.00M |